Peptide Graded

CJC-1295

Is CJC-1295 legal in the US?

No. It is not approved and is sold as a research chemical.

BSome human evidenceNot approvedas of 2026-10-26

CJC-1295 is not approved by the FDA for any use and is sold as a research chemical. Its nominations for the compounding bulks list were withdrawn in September 2024, and in December 2024 the FDA's Pharmacy Compounding Advisory Committee voted against adding it, so it is not eligible for pharmacy compounding either. 785

No. It has never been approved. Its compounding nominations were withdrawn in 2024, and the FDA's advisory committee voted against listing it. It is sold only as a research chemical. 785

Read the full CJC-1295 page

More on CJC-1295

Citations

  1. Teichman 2006, J Clin Endocrinol Metab: prolonged GH and IGF-1 stimulation by CJC-1295 in healthy adults pubmed.ncbi.nlm.nih.gov
  2. Ionescu 2006, J Clin Endocrinol Metab: pulsatile GH secretion persists during CJC-1295 stimulation pubmed.ncbi.nlm.nih.gov
  3. Jette 2005, Endocrinology: hGRF(1-29)-albumin bioconjugates, identification of CJC-1295 pubmed.ncbi.nlm.nih.gov
  4. 2026, Front Endocrinol: performance-enhancing peptides modulating the GH-IGF-1 axis, review pubmed.ncbi.nlm.nih.gov
  5. FDA: certain bulk drug substances for use in compounding may present significant safety risks fda.gov
  6. 1994, J Clin Endocrinol Metab: D-Ala2 GHRH(1-29) half-life and clearance in normal men pubmed.ncbi.nlm.nih.gov
  7. Lexology, September 2024: FDA removes certain peptide bulk drug substances from Category 2 lexology.com
  8. FDA briefing document, Pharmacy Compounding Advisory Committee, December 2024 fda.gov

Reference information only, not medical advice. Drawn from the CJC-1295 article, fact-checked against the cited sources. No dosing anywhere on this site.